We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+10.09%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$390M
AUM Growth
+$4.4M
Cap. Flow
-$11.6M
Cap. Flow %
-2.97%
Top 10 Hldgs %
36.69%
Holding
189
New
3
Increased
22
Reduced
93
Closed
8

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$8.09M
2
QRVO icon
Qorvo
QRVO
+$3.18M
3
DXCM icon
DexCom
DXCM
+$296K
4
TEAM icon
Atlassian
TEAM
+$225K
5
QLYS icon
Qualys
QLYS
+$221K

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$9.79M
2
CNC icon
Centene
CNC
+$1.4M
3
AAPL icon
Apple
AAPL
+$1.26M
4
AMZN icon
Amazon
AMZN
+$757K
5
LULU icon
lululemon athletica
LULU
+$746K

Sector Composition

Rank Sector Weight
1 Healthcare 24.4%
2 Technology 24.34%
3 Consumer Discretionary 11.23%
4 Communication Services 8.9%
5 Consumer Staples 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDSN icon
126
Nordson
NDSN
$17.2B
$339K 0.09%
1,765
-160
-8% -$30.8K
VMC icon
127
Vulcan Materials
VMC
$36.9B
$339K 0.09%
2,501
-21
-0.8% -$2.64K
KMB icon
128
Kimberly-Clark
KMB
$36B
$338K 0.09%
2,290
– –
DAL icon
129
Delta Air Lines
DAL
$59.3B
$335K 0.09%
10,950
– –
TSM icon
130
TSMC
TSM
$2.19T
$320K 0.08%
3,950
– –
AMGN icon
131
Amgen
AMGN
$223B
$308K 0.08%
1,210
– –
DOW icon
132
Dow Inc
DOW
$21.6B
$308K 0.08%
6,551
-512
-7% -$23K
PGEN icon
133
Precigen
PGEN
$2.57B
$306K 0.08%
87,544
– –
OTEX icon
134
Open Text
OTEX
$6B
$301K 0.08%
7,125
– –
ICLR icon
135
Icon
ICLR
$12.8B
$297K 0.08%
1,555
– –
SAP icon
136
SAP
SAP
$239B
$296K 0.08%
1,900
– –
UN
137
DELISTED
Unilever NV New York Registry Shares
UN
$293K 0.08%
4,850
– –
COF icon
138
Capital One
COF
$133B
$287K 0.07%
3,989
-703
-15% -$47K
DD icon
139
DuPont de Nemours
DD
$19.2B
$286K 0.07%
4,110
-280
-6% -$19.6K
NKE icon
140
Nike
NKE
$61.4B
$279K 0.07%
2,225
– –
NTES icon
141
NetEase
NTES
$84.5B
$273K 0.07%
3,000
– –
DOV icon
142
Dover
DOV
$28.5B
$270K 0.07%
2,493
– –
DHR icon
143
Danaher
DHR
$145B
$269K 0.07%
1,411
– –
YUM icon
144
Yum! Brands
YUM
$40.2B
$266K 0.07%
2,914
– –
OEF icon
145
iShares S&P 100 ETF
OEF
$20.5B
$263K 0.07%
1,690
– –
JKHY icon
146
Jack Henry & Associates
JKHY
$11B
$261K 0.07%
1,605
– –
BA icon
147
Boeing
BA
$186B
$260K 0.07%
1,574
-522
-25% -$89K
IJR icon
148
iShares Core S&P Small-Cap ETF
IJR
$112B
$256K 0.07%
3,647
– –
MRSH
149
Marsh
MRSH
$90.8B
$252K 0.06%
2,193
– –
ZBH icon
150
Zimmer Biomet
ZBH
$18.3B
$252K 0.06%
1,910
– –
4 5
6
7 8

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q3 2020 Portfolio in Review

As of Q3 2020, Dixon Hubard Feinour & Brown held 189 positions worth $390M, up 1.1% from $385M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2020 filing shows 3 new, 22 increased, 93 reduced and 8 closed positions. Its largest new stake was Qorvo: 25,635 shares worth $3.31M. The largest sale was Edwards Lifesciences, an estimated $9.79M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Dixon Hubard Feinour & Brown's largest Q3 2020 buy was Qorvo: 25,635 shares worth $3.31M.
  • Dixon Hubard Feinour & Brown added most to UnitedHealth in Q3 2020, an estimated $8.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2020 reduction was Apple, cutting an estimated $1.26M.
  • Dixon Hubard Feinour & Brown fully exited Edwards Lifesciences in Q3 2020, selling an estimated $9.79M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 37% of its $390M portfolio in Q3 2020.
  • Dixon Hubard Feinour & Brown opened 3 new positions and closed 8 in Q3 2020.
  • Dixon Hubard Feinour & Brown's portfolio value rose 1.1% quarter-over-quarter to $390M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2020, filed 12 Nov 2020.